Tegoprazan to prevent stomach problems after stroke
Treatments studied
Part of Brain & nervous system, Digestive system, Heart & circulation clinical trials.
This study tests a stomach-protecting medicine called tegoprazan for people who have had a stroke and are starting antiplatelet therapy. It aims to prevent stomach complications like ulcers or bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 or older.
- You were just hospitalized for an ischemic stroke or mini-stroke (TIA) and are starting an antiplatelet medicine (like aspirin or clopidogrel) for the first time.
- You have not had a stomach ulcer or gastrointestinal bleeding in the last year.
- You are not currently taking blood thinners (like warfarin or apixaban).
- You can have an endoscopy (a camera test for your stomach) if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called zastaprazan, which helps reduce stomach acid, to see if it can prevent bleeding in the stomach and intestines for people who are on blood thinners after a stroke. If you are taking blood thinners, this medicine might lower your risk of serious stomach bleeding.
This trial tests a new anti-platelet drug called Tiprogrel to prevent another stroke in people who recently had a minor stroke or a transient ischemic attack (TIA) with certain artery narrowing or plaques. It aims to see if this medicine is safe and works better than current treatments.
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
This trial tests whether adding ticagrelor or cilostazol to aspirin is better than aspirin alone for preventing another stroke. It is for patients who recently had a minor stroke or a transient ischemic attack (TIA) caused by a blockage in a large artery.
This trial tests whether switching to a simpler antiplatelet medication (ticagrelor) after a mild stroke or high-risk TIA can prevent another stroke while reducing the risk of bleeding. It is for people who have not received clot-busting treatment or had a large stroke.
This study tests a new tablet in healthy adults to see how the body processes it and whether food changes its effects. It helps determine the right dose and safety for future patients.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.